FDA Reverses Surprise Rejection of Moderna's mRNA Flu Vaccine

The Food and Drug Administration reversed course on its surprise rejection of Moderna's mRNA-based influenza vaccine, agreeing to consider the company's application just a week after initially refusing it. Reports indicate the Trump administration's vaccine policy chief had overruled FDA scientists to initially reject the shot, raising questions about political interference in public health decisions.